VONDA GAITOR: Open Payments
NPI 1780686519 · MARRERO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,340 in 11 payments from 10 companies in 2025. Trend: 2023 $142 · 2024 $1,321 · 2025 $1,340
Food & beverage: $1,340
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $250 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $140 |
| Organon LLC | 1 | $138 |
| Alexion Pharmaceuticals, Inc. | 1 | $135 |
| Edwards Lifesciences Corporation | 1 | $125 |
| Gilead Sciences, Inc. | 1 | $121 |
| Teva Pharmaceuticals USA, Inc. | 1 | $117 |
| GENZYME CORPORATION | 1 | $110 |
| Insmed, Inc. | 1 | $102 |
| ViiV Healthcare Company | 1 | $102 |
Products named: Kerendia, VTAMA, STRENSIQ, WAINUA, UZEDY, DUPIXENT, Arikayce, APRETUDE.
Industry payments across LA — which companies pay providers there.
